Prevalence of Working Memory Impairment in Drug Naive Schizophrenic Patients in a Tertiary Care Hospital

被引:1
作者
Goit, Bharat Kumar [1 ]
Khattri, Jai Bahadur [2 ]
机构
[1] Janaki Med Coll, Dept Psychiat, Janakpur, Nepal
[2] Manipal Coll Med Sci, Dept Psychiat, Pokhara, Nepal
关键词
age of onset; memory; schizophrenia; PERFORMANCE; DEFICIT;
D O I
10.31729/jnma.4642
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Schizophrenia is a mental disorder in which dear consciousness and the intellectual capacity are usually maintained, although certain cognitive deficits may evolve in the course of illness. Working memory impairment in schizophrenia affects the course, outcome, and quality of life of the patient significantly. The aim of the study was to find out the prevalence of working memory impairment in drug naive schizophrenic patients. Methods: This descriptive cross-sectional study was done in a tertiary care hospital, from June 2015 to December 2015 after taking ethical clearance from institutional review committee registration number 38970/062/063. Convenience sampling was done. The samples of 30 schizophrenic patients between the ages of 15 to 45 years were enrolled from the inpatient and outpatient unit of department according to inclusion and exclusion criteria. Data was collected and entry was done in Epi Info ver.7 , point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data. Results: The prevalence of working memory impairment was 26 (86.7%) in digit span forward test and 27 (90%) in digit span backward test. The mean age of patients was 27.5 years and the age of onset of schizophrenia was mainly in the age group between 16 to 25 years 16 (53.3%). Conclusions: These finding suggests high prevalence of working memory impairment in schizophrenic patients.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 23 条
  • [1] [Anonymous], 2018, The ICD-11 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines
  • [2] [Anonymous], NEPALESE J PSYCHIAT
  • [3] CLINICAL SERVICES RESEARCH
    ATTKISSON, C
    COOK, J
    KARNO, M
    LEHMAN, A
    MCGLASHAN, TH
    MELTZER, HY
    OCONNOR, M
    RICHARDSON, D
    ROSENBLATT, A
    WELLS, K
    WILLIAMS, J
    HOHMANN, AA
    [J]. SCHIZOPHRENIA BULLETIN, 1992, 18 (04) : 561 - 626
  • [4] Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal
    Banerjee, Indrajit
    Roy, Bedanta
    Sathian, Brijesh
    Banerjee, Indraneel
    Chakraborty, Prasanta Kumar
    Saha, Archana
    [J]. BMC PSYCHIATRY, 2013, 13
  • [5] Central Bureau of Statistics (NP) National Planning Commission Secretariat, 2012, NAT POP HOUS CENS 20
  • [6] Socio-demographic correlates of treatment response among patients with schizophrenia in a tertiary hospital in South-East Nigeria
    Ezeme, Mark S.
    Uwakwe, Richard
    Ndukuba, Appolos C.
    Igwe, Monday N.
    Odinka, Paul C.
    Amadi, Kennedy
    Obayi, Nichodemus O.
    [J]. AFRICAN HEALTH SCIENCES, 2016, 16 (04) : 1036 - 1044
  • [7] Pattern of psychiatric morbidity among the patients admitted in a private psychiatric clinic
    Fahmida, A.
    Wahab, M. A.
    Rahman, M. M.
    [J]. BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2009, 8 (1-2): : 23 - 28
  • [8] Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159
  • [9] Neurocognitive deficit in schizophrenia: A quantitative review of the evidence
    Heinrichs, RW
    Zakzanis, KK
    [J]. NEUROPSYCHOLOGY, 1998, 12 (03) : 426 - 445
  • [10] Baseline neurocognitive deficits in the CATIE schizophrenia trial
    Keefe, Richard S. E.
    Bilder, Robert M.
    Harvey, Philip D.
    Davis, Sonia M.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Miller, Del D.
    Canive, Jose M.
    Adler, Lawrence W.
    Manschreck, Theo C.
    Swartz, Marvin
    Rosenheck, Robert
    Perkins, Diana O.
    Walker, Trina M.
    Stroup, T. Scott
    McEvoy, Joseph P.
    Lieberman, Jeffrey A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) : 2033 - 2046